PRESS RELEASE:
2007 FDA Regulatory and Compliance Symposium at Harvard Announces to Analyze Conflicts of Interest with Health Professionals
  • Managing Risks - From Pipeline to Patient
  • Classes Held in Harvard University's Annenberg Hall, Sanders Theatre and Faculty Club, Cambridge, MA
  • August 22 - 24, 2007
  • Symposium Hotels: The Charles Hotel, Cambridge, MA
  • www.FDASymposium.com
PRESS RELEASE
Phone: 800-684-4549
Email: registration@hcconferences.com
Website: www.FDASymposium.com

CAMBRIDGE, MA USA -- PHARMA UPDATE NEWS SERVICE™ -- APRIL 30, 2007: The Third FDA Regulatory and Compliance Symposium, www.FDASymposium.com, August 22 - 24, 2007, in Cambridge, MA announced today that it will offer a special session on Industry Collaboration and Interactions With Health Professionals - Can Conflicts of Interest Be Properly Managed?

THE VENUES AT HARVARD

Classes Held: Harvard University's Annenberg Hall, Lowell Hall, Science Center and the Harvard Faculty Club
Symposium Hotel: The Charles Hotel

CONFLICTS OF INTEREST

On Wednesday, August 22, 2007 the FDA Symposium will off the following special session:

Panel Discussion: Industry Collaboration and Interactions With Health Professionals - Can Conflicts of Interest Be Properly Managed?

Marc Wilenzick, Esq.
Senior Corporate Counsel, Pfizer, New York, NY
Tom Stossel, MD
Department of Medicine, Harvard Medical School, Co-Director, Division of Hematology, Brigham and Women's Hospital, Boston, MA

Cathryn Clary, MD, MBA
Vice President, External Medical Affairs, Pfizer, New York, NY
David Rothman, PhD
Bernard Schoenberg Professor of Social Medicine, Director of the Center for the Study of Society and Medicine, Columbia College of Physicians and Surgeons, Professor of History, Columbia University, New York, NY

KEYNOTE SPEAKERS
Jerry Avorn, MD
Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Author, Powerful Medicines and The Benefits, Risks, and Costs of Prescription Drugs, Boston, MA
Sheldon Bradshaw, Esq.
Chief Counsel, FDA, Washington, DC
Lester Crawford, DVM, PhD
Senior Counsel, Policy Directions, Inc., Former Commissioner, FDA, Washington, DC
Scott Gottlieb, MD
Resident Fellow, American Enterprise Institute, Former Commissioner for Medical and Scientific Affairs, FDA, Washington, DC
Sonali Gunawardhana, JD
Regulatory Counsel, Center for Devices and Radiological Health, FDA, Rockville, MD
Joseph Mahady
President, Global Business, Wyeth Pharmaceuticals, Collegeville, PA
Arthur Miller, Esq.
Bruce Bromley Professor of Law, Harvard Law School, Cambridge, MA
Wayne Pines
President, FDA Alliance, President, Regulatory Services and Healthcare, APCO Worldwide, Former Associate Commissioner for Public Affairs, FDA, Washington, DC

Lucy Rose, MBA
President, Lucy Rose and Associates, LLC; Former Director of the Office of Training and Communications and DDMAC, CDER, FDA
David Rothman, PhD
Bernard Schoenberg Professor of Social Medicine, Director of the Center for the Study of Society and Medicine, Columbia College of Physicians and Surgeons, Professor of History, Columbia University, New York, NY
Jim Sheehan, Esq.
Associate United States Attorney, U.S. Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA
Tom Stossel, MD
Department of Medicine, Harvard Medical School, Co-Director, Division of Hematology, Brigham and Women's Hospital, Boston, MA
Daniel Troy, Esq.
Partner, Sidley Austin Brown & Wood, Former Chief Counsel, Office of the General Counsel, FDA, Washington, DC
Marc Wilenzick, Esq.
Senior Corporate Counsel, Pfizer, New York, NY
Helen Winkle
Director, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, FDA
Susan Wood, PhD
Research Professor, School of Public Health and Health Services, George Washington University, Former Assistant Commissioner for Women's Health, and Director of the Office of Women's Health, FDA, Washington, DC

FEATURED FACULTY
David Balto, Esq.
Private Practice; Former Policy Director of the Bureau of Competition of the Federal Trade Commission, Washington, DC

Charles Bennett, MD, PhD
Professor of Medicine, Northwestern Medical School, Chicago, IL

Richard J. Berman, Esq.
Partner, Arent Fox LLP, Washington, DC

Robert Campbell, JD, MPH, PhD
Health Services Researcher, VISN 8 Patient Safety Center, Tampa, FL

Mike Celentano
Associate Director, Supply Chain Systems, Purdue Pharma, Stamford, CT (invited)

Dave Ceryak, Esq.
Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN

Cathryn Clary, MD, MBA
Vice President, External Medical Affairs, Pfizer, New York, NY

Fran Cunningham, PharmD
Director, VHA Medication Safety Center, Chicago, IL

Kelly Freeman, PhD, MSc
Director, US Affiliate, Compliance and Ethics, Eli Lilly and Company, Indianapolis, IN

Dustin French, PhD
Health Economist, VISN 8 Patient Safety Center, Tampa, FL

Arnold Friede, JD
Senior Corporate Counsel, Pfizer; Former Associate Chief Counsel, FDA, New York, NY

John (Jack) Garvey
Vice President, Compliance & Quality Management, THE WEINBERG GROUP, Princeton, NJ

Gary Giampetruzzi, Esq.
Senior Corporate Counsel, Deputy Compliance Officer, International Investigations and Programs, Pfizer, New York, NY

Stephen Goldman, MD, FAPM, FAPA
Managing Member, Stephen A. Goldman Consulting Services, Morris Plains, NJ

Linda Horton, JD
Partner, Hogan & Hartson; Former Director of International Policy and Deputy Chief Counsel for Regulations, FDA, Brussels, Belgium and Washington, DC

John Kamp, JD, PhD
Executive Director, Coalition for Healthcare Communication; Of Counsel, Wiley Rein, Washington, DC

Anjali Kataria
Co-Founder, FDA-Conformia CRADA Study, Principal Investigator, Sunnyvale, CA

Keith Korenchuk, JD, MPH
Of Counsel, Covington & Burling, Washington, DC

Greg Koski, MD, PhD, CPI
Associate Professor of Anesthesia, Senior Scientist, Institute for Health Policy, Massachusetts General Hospital, Partners Health Care System, Harvard Medical School, Former Director, Office for Human Research Protections, Office of Public Health and Science, Office of the Secretary, HHS, Boston, MA

Daniel Kracov, JD
Partner, Co-Head, Pharmaceutical and Medical Device Practice, Arnold & Porter, Washington, DC

Michael Labson, JD
Partner, Covington & Burling, Washington, DC

Geoff Levitt, Esq.
Vice President and Chief Counsel, Regulatory and Research, Wyeth Pharmaceuticals, Collegeville, PA

Douglas Long, MBA
Vice President, Industry Relations, IMS Health, Totowa, NJ

Claudio Pincus
President, The Quantic Group, Livingston, NJ

Peter Pitts
President, Center for Medicines in the Public Interest; Senior Vice President for Global Health Affairs, Manning, Selvage & Lee; Former Associate Commissioner for External Relations, FDA, New York, NY

R. Owen Richards
President, Quantic Regulatory Services, LLC, Livingston, NJ

Linda Rivero
President, Voice of Persuasion, Alexandria, VA

Nancy Singer
President of Compliance-Alliance; Former Prosecutor, U.S. Department of Justice, Washington, DC

Thomas Sobol, Esq.
Managing Partner, Hagens Berman Sobol Shapiro, Cambridge, MA

Kristina Spitler
Training Manager, Almac Clinical Services, Durham, NC

Alex Sugerman-Brozan
Director, Prescription Access Litigation (PAL) Project, Boston, MA

Ivan Wasserman
Partner, Kelley Drye & Warren, Washington, DC

SPONSORED BY







EXHIBIT & SPONSORSHIP INFORMATION
Andrew McSherry
300 N. Washington St., Suite 200
Falls Church, VA 22046
Phone: (703) 538-7643
Fax: (703) 538-7007
E-mail: amcsherry@fdanews.com
Joni Lipson
100 North 20th Street, 4th Floor
Philadelphia, PA 19103
Phone: (800) 546-3750
Fax: (215) 545-8107
E-mail: joni.lipson@rmpinc.com



REGISTRATION INFORMATION

For further registration information, go to www.fdasymposium.com/registration.html, call 800-684-4549, email registration@hcconferences.com or write:

FDA Symposium Office
3291 West Wilson Road
Pahrump, NV 89048